PubMed HealthSearch

PubMed · 9074852

Test characteristics and decision rules.

Abstract

We have demonstrated using several examples how different test characteristics can be used to assist clinicians in making better decisions for their patients. These probabilistic models may seem confusing and difficult to implement. Some general rules may help, such as SnNout and SpPin. Clinicians should know the test characteristics and decision rules for the acute problems they may face. For chronic conditions, advanced planning may be helpful. Electronic medical record systems may be able to incorporate these at the user interface. The improvements in hand-held computers may bring clinical decision-support systems directly to the point of service. We may also begin to see laboratories report test characteristics for important conditions as likelihood ratios (we already see estimates of the risk of heart disease corresponding to different lipid ratios). We also suspect that the medical literature will report likelihood ratios more frequently. As practice networks develop more sophisticated disease-tracking mechanisms, clinicians will be able to obtain estimates of disease prevalence more appropriate to their practice. Ultimately, for physicians to make better decisions, appropriate data are needed, including accurate estimates of test characteristics and of disease probability.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H C Barry, M H Ebell. 1997. Test characteristics and decision rules.. https://doi.org/10.1016/s0889-8529(05)70233-4

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Developing and expanding contributions of the global laboratory network for poliomyelitis eradication, 1997-1999.

In 1988, the World Health Assembly resolved to eradicate poliomyelitis globally by 2000. Substantial progress toward achieving this goal has been reported from all countries where polio is endemic, and three regions of the World Health Organization (WHO) (American Region, European Region, and Western Pacific Region) appear to be free of indigenous wild poliovirus transmission. One key strategy for polio eradication is establishing sensitive surveillance systems for polio (through notification of acute flaccid paralysis [AFP] cases) and poliovirus. To ensure that specimens from AFP cases undergo appropriate processing for viral isolation, WHO has established a global laboratory network. This report describes the proficiency of the network and provides updates on structure, accreditation, performance, expanding activities, and future plans.

Clinical Laboratory Techniques

Guidelines for surveillance, prevention, and control of West Nile virus infection--United States.

The introduction of West Nile (WN) virus in the northeastern United States during the summer and fall of 1999 raised the issue of preparedness of public health agencies to handle sporadic and outbreak-associated vector-borne diseases. In many local and state health departments, vector-borne disease capacity has diminished. Because it is unknown whether the virus can persist over the winter, whether it has already or will spread to new geographic locations, and the public health and animal health implications of this introduction, it is important to establish proactive laboratory-based surveillance and prevention and control programs to limit the impact of the virus in the United States. On November 8 and 9, 1999, CDC and the U.S. Department of Agriculture (USDA) cosponsored a meeting of experts representing a wide range of disciplines to review the outbreak and to provide input and guidance on the programs that should be developed to monitor WN virus activity and to prevent future outbreaks of disease. This report summarizes the guidelines established during this meeting.

Clinical Laboratory Techniques